Valuation: ConvaTec Group Plc

Market Cap 5.69B 5.08B 4.73B 4.3B 8.12B 551B 8.15B 56.89B 22.29B 281B 21.37B 20.9B 901B P/E 2026 *
22.6x
P/E 2027 * 15.5x
Enterprise Value 7.09B 6.33B 5.89B 5.36B 10.12B 686B 10.16B 70.92B 27.79B 350B 26.63B 26.05B 1,123B EV / Sales 2026 *
2.78x
EV / Sales 2027 * 2.53x
Free-Float
95.09%
Yield 2026 *
2.73%
Yield 2027 * 3.12%
1 day+3.29%
1 week+1.57%
Current month+1.38%
1 month-0.45%
3 months+3.29%
6 months-1.79%
Current year-9.54%
1 week 213
Extreme 213
222
1 month 209.2
Extreme 209.2
222
Current year 193
Extreme 193
259.3
1 year 193
Extreme 193
259.3
3 years 193
Extreme 193
311.2
5 years 165.3
Extreme 165.3
311.2
10 years 113.25
Extreme 113.25
349.1
Manager TitleAgeSince
Chief Executive Officer 62 03/08/2025
Director of Finance/CFO 51 03/08/2025
Chief Operating Officer - 31/05/2026
Director TitleAgeSince
Director/Board Member 71 13/08/2017
Chairman 78 29/09/2019
Director/Board Member 62 01/03/2020
Date Insider Type Main position Quantity % Market Cap. Importance
26/05/26 Buy

Chief Executive Officer

50,000 0.0026%
26/05/26 Buy

Chief Financial Officer

24,993 0.0013%
17/03/26 Exercice

Chief Executive Officer

106,137 0.0054%
Change 5-day change 1-year change 3-year change Capi.($)
+3.29%+1.57%-9.09%+5.36% 5.69B
+1.13%+2.15%-25.29%+2.94% 172B
+0.83%+2.43%-8.31%+17.77% 113B
+0.13%+0.69%-25.09%+3.95% 106B
+2.34%+2.49%-47.36%-10.38% 75.31B
+0.78%+4.79%+3.10%+73.94% 61.8B
+0.12%+3.62%+12.66%+67.70% 52.93B
+0.55%+3.93%-2.82%-30.87% 50.05B
+0.95%-0.08%-17.61%+17.13% 40.81B
-0.36%-1.46%+23.55%+1.23% 31.74B
Average +0.98%+1.91%-9.63%+14.88% 71.02B
Weighted average by Cap. +0.85%+2.09%-15.26%+13.42%

Financials

2026 *2027 *
Net sales 2.55B 2.28B 2.12B 1.93B 3.64B 247B 3.66B 25.54B 10.01B 126B 9.59B 9.38B 404B 2.73B 2.44B 2.27B 2.06B 3.9B 264B 3.92B 27.32B 10.71B 135B 10.26B 10.04B 433B
Net income 250M 223M 208M 189M 357M 24.18B 358M 2.5B 979M 12.33B 938M 918M 39.56B 364M 325M 303M 275M 520M 35.26B 522M 3.64B 1.43B 17.98B 1.37B 1.34B 57.69B
Net Debt 1.4B 1.25B 1.17B 1.06B 2B 136B 2.01B 14.02B 5.49B 69.2B 5.27B 5.15B 222B 1.22B 1.09B 1.02B 925M 1.75B 118B 1.75B 12.24B 4.79B 60.38B 4.6B 4.49B 194B
Projected Income Statement - Annual - ConvaTec Group Plc
Logo ConvaTec Group Plc
ConvaTec Group Plc specializes in the development, manufacturing and marketing of medical devices and products for ostomy care, wound care, and incontinence. The group also offers perfusion devices. Net sales break down by area of activity as follows: - wound care (30.9%): antimicrobial dressings, occlusive dressings, compression bandages, etc.; - ostomy care (27.7%): skin barriers, one-piece bags, 2-piece appliance bags, urostomy bags, etc.; - incontinence care (22%); - infusion (19.4%). At the end of 2025, the group operated 7 production sites worldwide. Net sales are distributed geographically as follows: Europe (29.6%), North Americas (55.7%) and other (14.7%).
Employees
10,000
Date Price Change Volume
09/10/26 GBX 220.00 +3.29% 5,198,612
08/10/26 GBX 213.00 -1.75% 7,284,064
07/10/26 GBX 216.80 -0.73% 7,217,421
06/10/26 GBX 218.40 +0.18% 5,457,194
05/10/26 GBX 218.00 +0.65% 6,911,082
Trader
Investor
Global
Quality
ESG MSCI
AAA
Ratings Surperformance© - ConvaTec Group Plc
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
19
Last Close Price
2.911USD
Average target price
4.032USD
Spread / Average Target
+38.48%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - ConvaTec Group Plc
  1. Stock Market
  2. Stocks
  3. CTEC Stock